EPharmacy Workshop 18-19 December 2008-Minutes

From IHE Wiki
Revision as of 04:54, 23 January 2009 by Geert.claeys (talk | contribs) (→‎White Paper Pharmacy - review)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Venue

  • Brussels, 18-19 December 2008

Participants

N. Canu (Phast, France) S. Letellier (EAHP/Phast, France), S. Juvin (GIP DMP, France) C. Rica (GIP DMP, France) F. Macary (GMSIH, Fhrance) K. Bourquard (GMSIH, France), M. Sprenger (NICTIZ, Netherlands), J. Nunez (Indra, Spain) L. Tzimis (EAHP, Greece) S. Thun (DIMDI, Germany) G. Claeys (Agfa Healthcare)

All Documents

IHE Pharmacy Application

  • Sponsors (EAHP, NICTIZ, PHAST, GMSIH) submitted the application forms to IHE International.
  • Note : In the mean time, IHE International board provisional approved the creation of IHE Pharmacy domain, subject to 45 days announcement period.

White Paper Pharmacy - review

  • Document : here (contains some updates of the meeting)
  • Note : feedback is captured by the different chapter editors; only feedback that span multiple chapters is covered here; the names between brackets are the action owners.
  • Chapter2 : streamline glossary with HL7 glossary (T. DeJong)
  • Chapter 4/6: explicitly link the Use Cases to the Business Processes (Michiel/Geert)
  • Chapter 5 (Information Model - new) : describe the real-world Information Model : main information entities (e.g. medication, prescription) and their relations (Sylvie).
  • Chapter 6 (Use Cases):
    • Chapter must be re-worked to better align with other chapters(Geert)
    • New hospital Use Cases :
      • Admission Use Cases (previously called the English Use Case);
      • Simple Discharge Prescription (exit medication)
      • Dispensed Medication for outpatients
  • Chapter 7 (Actors)
    • The definition of the different actors is reworked in order to maximize re-use in the different domains. The new list of actors is available here. All chapters must use the new actor definitions
  • Chapter 8
    • Prescription use cases can be implemented in 2 modes: 1. publish/pull mode (aka decentralized mode) where sender publishes the prescription and the consumer pulls the prescription; 2. Direct push mode (aka pnt-to-pnt) where the senders directly sends the prescription to the consumer
  • Chapter 10 (XDS Architecture)
    • Proposed architecture must describe the target architecture, not the current architecture (Francois)
  • Chapter 11 (Standards)(Francois)
    • HL7v2 messages will be used for hospital pharmacy due to the installed base
    • HL7v3 messages for community pharmacy :
      • still in trial implementation phase; normative expected end 2009
      • proprietary extensions in different countries : e.g. UK, Canada
      • Activities focus om Medication Information Model (DMIM)
    • XDS/CDA (preferred approach for community pharmacy):
      • CDA document contains prescription and dispensed medication
      • XDS infrastructure for sharing persistent documents (e.g. medication record, prescriptions)
      • NaV profile for sending notifications
      • XDM profile for pnt-to-pnt connections
    • Required extensions for XDS/CDA:
      • Add metadata (to XDS registry or in CDA document) to link prescriptions and dispensed medication
      • CDA implementation profile for prescriptions, dispensed medication and pharmaceutical advise
      • Map CDA to HL7v2

Next steps

  • Each chapter editor exclusively updates its chapter; comments on other chapters should be send to the corresponding chapter owner; baseline version: 0.7;
  • Updated chapters are published on the ftp site; a compiled version of all updated chapters will be published a few days before the next ftf meeting

Timeline

  • 22 Jan 2009 : upload new version of the different chapters (chapter editors)
  • 23 Jan 2009 : upload new version of the White Paper (Geert)
  • 28 Jan 2009 : ftf meeting to complete the White Paper
  • Q1-2/09 : start development of technical framework

Next meetings

See here